159 related articles for article (PubMed ID: 2185966)
1. Long-term treatment with the somatostatin analogue SMS 201-995: alternative to pancreatectomy in persistent hyperinsulinaemic hypoglycaemia of infancy.
Glaser B; Landaw H
Digestion; 1990; 45 Suppl 1():27-35. PubMed ID: 2185966
[TBL] [Abstract][Full Text] [Related]
2. Persistent hyperinsulinaemic hypoglycaemia of infancy: long-term treatment with the somatostatin analogue Sandostatin.
Glaser B; Landau H; Smilovici A; Nesher R
Clin Endocrinol (Oxf); 1989 Jul; 31(1):71-80. PubMed ID: 2688998
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin analogue SMS 201-995 in the short-term management of neonatal hyperinsulinism due to nesidioblastosis.
Sullivan MJ; Taylor BJ; Broadbent RS; Yun K; Lovell-Smith M; Donald RA
Aust Paediatr J; 1988 Dec; 24(6):375-8. PubMed ID: 3071997
[TBL] [Abstract][Full Text] [Related]
4. Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy.
DeClue TJ; Malone JI; Bercu BB
J Pediatr; 1990 May; 116(5):747-50. PubMed ID: 2184212
[No Abstract] [Full Text] [Related]
5. The effects of a somatostatin analogue on the metabolism of an infant with Beckwith-Wiedemann syndrome and hyperinsulinaemic hypoglycaemia.
Gerver WJ; Menheere PP; Schaap C; Degraeuwe P
Eur J Pediatr; 1991 Jul; 150(9):634-7. PubMed ID: 1915515
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin analogue in short term management of hyperinsulinism.
Kirk JM; Di Silvio L; Hindmarsh PC; Brook CG
Arch Dis Child; 1988 Dec; 63(12):1493-4. PubMed ID: 3232999
[TBL] [Abstract][Full Text] [Related]
7. Ten years' experience of persistent hyperinsulinaemic hypoglycaemia of infancy.
Tyrrell VJ; Ambler GR; Yeow WH; Cowell CT; Silink M
J Paediatr Child Health; 2001 Oct; 37(5):483-8. PubMed ID: 11885714
[TBL] [Abstract][Full Text] [Related]
8. Preoperative use of octreotide in a newborn with persistent hyperinsulinemic hypoglycemia of infancy.
Apak RA; Yurdakök M; Oran O; Senocak ME; Cağlar M
J Pediatr Endocrinol Metab; 1998 Mar; 11 Suppl 1():143-5. PubMed ID: 9642652
[TBL] [Abstract][Full Text] [Related]
9. Persistent hyperinsulinaemic hypoglycaemia of infancy: case report.
Semiz S; Bircan I; Akçurin S; Mihçi E; Melikoglu M; Karagüzel G; Kiliçaslan B; Karpuzoğlu G
East Afr Med J; 2002 Oct; 79(10):554-6. PubMed ID: 12635764
[TBL] [Abstract][Full Text] [Related]
10. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy.
Baş F; Darendeliler F; Demirkol D; Bundak R; Saka N; Günöz H
J Pediatr Endocrinol Metab; 1999; 12(6):873-8. PubMed ID: 10614546
[TBL] [Abstract][Full Text] [Related]
11. Normal growth after administration of octreotide: report on a case of persistent hyperinsulinemic hypoglycemia of infancy treated by continuous subcutaneous injection of octreotide.
Kuno T; Fujita I; Ohta M; Kanemitsu H; Miyazaki S; Miyamoto S
Endocr J; 1999 Mar; 46 Suppl():S47-9. PubMed ID: 12054118
[No Abstract] [Full Text] [Related]
12. Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.
Hawdon JM; Ward Platt MP; Lamb WH; Aynsley-Green A
Arch Dis Child; 1991 Mar; 66(3):341-3. PubMed ID: 2025013
[TBL] [Abstract][Full Text] [Related]
13. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy.
Glaser B; Hirsch HJ; Landau H
J Pediatr; 1993 Oct; 123(4):644-50. PubMed ID: 8410523
[TBL] [Abstract][Full Text] [Related]
14. Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report.
Skajaa GO; Mathiesen ER; Iyore E; Beck-Nielsen H; Jimenez-Solem E; Damm P
BMC Res Notes; 2014 Nov; 7():804. PubMed ID: 25404386
[TBL] [Abstract][Full Text] [Related]
15. Persistent hyperinsulinemic hypoglycemia of infancy: long-term outcome following subtotal pancreatectomy.
Mahachoklertwattana P; Suprasongsin C; Teeraratkul S; Preeyasombat C
J Pediatr Endocrinol Metab; 2000 Jan; 13(1):37-44. PubMed ID: 10689636
[TBL] [Abstract][Full Text] [Related]
16. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.
Kane C; Lindley KJ; Johnson PR; James RF; Milla PJ; Aynsley-Green A; Dunne MJ
J Clin Invest; 1997 Oct; 100(7):1888-93. PubMed ID: 9312191
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism.
Vezzosi D; Bennet A; Courbon F; Caron P
Clin Endocrinol (Oxf); 2008 Jun; 68(6):904-11. PubMed ID: 18031316
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of somatostatin analogue SMS 201-995 in the treatment of hypoglycaemia due to nesidioblastosis.
Wilson DC; Carson DJ; Quinn RJ
Acta Paediatr Scand; 1988 May; 77(3):467-70. PubMed ID: 2898862
[TBL] [Abstract][Full Text] [Related]
19. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism.
Thornton PS; Alter CA; Katz LE; Baker L; Stanley CA
J Pediatr; 1993 Oct; 123(4):637-43. PubMed ID: 8410522
[TBL] [Abstract][Full Text] [Related]
20. Histochemical, clinical, and in vitro beta cell responses in a neonate with persistent hyperinsulinaemic hypoglycaemia of infancy.
Panesar NS; Poon CW; Liew CT; Wong GW; Hjelm NM
Arch Dis Child Fetal Neonatal Ed; 1998 Sep; 79(2):F141-4. PubMed ID: 9828742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
